• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国孕32 - 35周出生且未接受免疫预防的早产儿的呼吸道合胞病毒病

Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.

作者信息

Ambrose Christopher S, Anderson Evan J, Simões Eric A F, Wu Xionghua, Elhefni Hanaa, Park C Lucy, Sifakis Frangiscos, Groothuis Jessie R

机构信息

From the *MedImmune Medical & Scientific Affairs, Gaithersburg, MD; †Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA; ‡Department of Pediatrics, University of Colorado, School of Medicine, and Department of Pediatrics, Children's Hospital Colorado, Aurora, CO; §former employee of MedImmune, Gaithersburg, MD; ¶Department of Pediatrics, University of Illinois, Chicago, IL; and ||Current: AstraZeneca, U.S. Medical Affairs, Gaithersburg, MD.

出版信息

Pediatr Infect Dis J. 2014 Jun;33(6):576-82. doi: 10.1097/INF.0000000000000219.

DOI:10.1097/INF.0000000000000219
PMID:24622396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4025592/
Abstract

BACKGROUND

The Respiratory Syncytial Virus (RSV) Respiratory Events Among Preterm Infants Outcomes and Risk Tracking (REPORT) study evaluated RSV disease burden in U.S. preterm infants 32-35 weeks gestational age (wGA) not receiving RSV prophylaxis.

METHODS

Preterm infants <6 months of age as of November 1st were followed prospectively at 188 clinics from September to May 2009-2010 or 2010-2011. Nasal and pharyngeal swabs were collected for medically attended acute respiratory illnesses (MAARI) and tested for RSV by qRT-polymerase chain reaction. Risk factors were assessed using multivariate Cox proportional hazard model adjusted for seasonality.

RESULTS

Of 1642 evaluable infants, 287 experienced RSV MAARI. Rates of RSV-related MAARI, outpatient lower respiratory tract illness, emergency department visits and hospitalization (RSVH) during November to March were 25.4, 13.7, 5.9 and 4.9 per 100 infant-seasons, respectively. Preschool-aged, nonmultiple-birth siblings and daycare attendance were consistently associated with increased risk of RSV. RSVH rates were highest in infants 32-34 and 35 wGA who were <6 months of age during November to March with daycare attendance or nonmultiple-birth, preschool-aged siblings (8.9 and 9.3 per 100 infant-seasons, respectively, versus 3.5 for all other infants, P<0.001). Chronologic age <3 months was associated with a higher RSVH rate for infants 35 wGA but not for infants 32-34 wGA.

CONCLUSIONS

In US preterm infants who were 32-35 wGA, <6 months on November 1st and not receiving RSV prophylaxis, the burden of RSV MAARI was 25 per 100 infant-seasons. The highest RSVH rates occurred among those with daycare attendance or nonmultiple-birth, preschool-aged siblings while they were <6 months of age during the RSV season.

摘要

背景

呼吸道合胞病毒(RSV)早产儿呼吸道事件结局与风险追踪(REPORT)研究评估了美国胎龄32 - 35周(wGA)且未接受RSV预防的早产儿的RSV疾病负担。

方法

截至11月1日年龄小于6个月的早产儿于2009 - 2010年或2010 - 2011年9月至5月在188家诊所进行前瞻性随访。收集因就诊的急性呼吸道疾病(MAARI)的鼻拭子和咽拭子,并通过定量逆转录聚合酶链反应检测RSV。使用针对季节性进行调整的多变量Cox比例风险模型评估危险因素。

结果

在1642名可评估婴儿中,287名经历了RSV MAARI。11月至3月期间,与RSV相关的MAARI、门诊下呼吸道疾病、急诊就诊和住院(RSVH)发生率分别为每100婴儿季25.4、13.7、5.9和4.9例。学龄前儿童、非多胞胎兄弟姐妹和日托出勤情况一直与RSV风险增加相关。在11月至3月期间,年龄小于6个月且有日托出勤或非多胞胎、学龄前兄弟姐妹的32 - 34周和35周wGA婴儿的RSVH发生率最高(分别为每100婴儿季8.9和9.3例,而所有其他婴儿为3.5例,P<0.001)。实际年龄小于3个月与35周wGA婴儿的RSVH发生率较高相关,但与32 - 34周wGA婴儿无关。

结论

在美国胎龄32 - 35周、11月1日年龄小于6个月且未接受RSV预防的早产儿中,RSV MAARI的负担为每100婴儿季25例。RSV季节期间,年龄小于6个月且有日托出勤或非多胞胎、学龄前兄弟姐妹的婴儿RSVH发生率最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2235/4025592/8b88026a3000/inf-33-0576-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2235/4025592/60d7e126751b/inf-33-0576-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2235/4025592/b778002ae20e/inf-33-0576-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2235/4025592/8b88026a3000/inf-33-0576-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2235/4025592/60d7e126751b/inf-33-0576-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2235/4025592/b778002ae20e/inf-33-0576-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2235/4025592/8b88026a3000/inf-33-0576-g005.jpg

相似文献

1
Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.美国孕32 - 35周出生且未接受免疫预防的早产儿的呼吸道合胞病毒病
Pediatr Infect Dis J. 2014 Jun;33(6):576-82. doi: 10.1097/INF.0000000000000219.
2
Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation.孕32至35周出生的美国早产儿的年龄及幼儿接触情况对呼吸道合胞病毒疾病的影响
PLoS One. 2016 Nov 29;11(11):e0166226. doi: 10.1371/journal.pone.0166226. eCollection 2016.
3
RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020.2003年至2020年极早产儿(出生孕周<29周)中与呼吸道合胞病毒相关的住院治疗及帕利珠单抗门诊使用情况
Hum Vaccin Immunother. 2022 Nov 30;18(6):2140533. doi: 10.1080/21645515.2022.2140533. Epub 2022 Nov 22.
4
Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29-34 wGA) infants without outpatient palivizumab administration.早产儿(出生时胎龄为 29-34 周)如未接受门诊帕利珠单抗治疗,其与呼吸道合胞病毒相关住院风险与胎龄相关。
Hum Vaccin Immunother. 2023 Aug;19(2):2252289. doi: 10.1080/21645515.2023.2252289. Epub 2023 Oct 12.
5
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.SENTINEL1:未接受免疫预防的 29 至 35 孕周出生美国婴儿呼吸道合胞病毒住院的两季研究。
Am J Perinatol. 2020 Mar;37(4):421-429. doi: 10.1055/s-0039-1681014. Epub 2019 Apr 16.
6
The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.2014年美国儿科学会呼吸道合胞病毒免疫预防指南对美国出生的早产儿的2014 - 2015年全国影响
Am J Perinatol. 2018 Jan;35(2):192-200. doi: 10.1055/s-0037-1606352. Epub 2017 Sep 7.
7
Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017.2011 - 2017年美国儿科学会免疫预防政策前后美国早产和足月婴儿呼吸道合胞病毒住院情况的最新报告
Hum Vaccin Immunother. 2021 May 4;17(5):1536-1545. doi: 10.1080/21645515.2020.1822134. Epub 2020 Oct 22.
8
Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012-2016.美国 2014 年儿科学会免疫预防指南发布前后,与足月婴儿相比,美国早产儿因呼吸道合胞病毒住院治疗的情况:2012-2016 年。
Am J Perinatol. 2018 Dec;35(14):1433-1442. doi: 10.1055/s-0038-1660466. Epub 2018 Jun 19.
9
SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.哨兵1:对美国29至35周胎龄且未接受免疫预防的婴儿因呼吸道合胞病毒住院情况的观察性研究。
Am J Perinatol. 2017 Jan;34(1):51-61. doi: 10.1055/s-0036-1584147. Epub 2016 May 27.
10
Impact of the 2014 American Academy of Pediatrics Immunoprophylaxis Policy on the Rate, Severity, and Cost of Respiratory Syncytial Virus Hospitalizations among Preterm Infants.2014 年美国儿科学会免疫预防政策对早产儿因呼吸道合胞病毒住院率、严重程度和费用的影响。
Am J Perinatol. 2020 Jan;37(2):174-183. doi: 10.1055/s-0039-1694008. Epub 2019 Aug 20.

引用本文的文献

1
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants.优化风险因素以指导韩国婴儿高效使用帕利珠单抗。
Pediatr Int. 2025 Jan-Dec;67(1):e70021. doi: 10.1111/ped.70021.
2
Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants.罗马尼亚婴儿使用帕利珠单抗预防呼吸道合胞病毒的依从性。
Vaccines (Basel). 2025 Feb 10;13(2):171. doi: 10.3390/vaccines13020171.
3
Healthcare resource utilisation and costs in infants with confirmed respiratory syncytial virus infections: a national population cohort study.

本文引用的文献

1
Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.中度早产儿应用呼吸道合胞病毒免疫预防的年龄阈值适宜性:一项队列研究。
JAMA Pediatr. 2013 Dec;167(12):1118-24. doi: 10.1001/jamapediatrics.2013.2636.
2
Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.小于 24 月龄儿童因呼吸道合胞病毒导致的住院治疗。
Pediatrics. 2013 Aug;132(2):e341-8. doi: 10.1542/peds.2013-0303. Epub 2013 Jul 22.
3
Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.
确诊呼吸道合胞病毒感染婴儿的医疗资源利用和费用:一项全国人群队列研究。
BMC Infect Dis. 2024 Oct 14;24(1):1152. doi: 10.1186/s12879-024-09971-0.
4
Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review.RSV 感染和幼儿(<5 岁)毛细支气管炎在初级保健和急诊科的疾病负担:系统文献综述。
Influenza Other Respir Viruses. 2024 Aug;18(8):e13344. doi: 10.1111/irv.13344.
5
Healthcare Utilization Among Infants Covered by Medicaid and Newly Diagnosed With Respiratory Syncytial Virus.医疗补助计划覆盖且新诊断出感染呼吸道合胞病毒的婴儿的医疗服务利用情况
Open Forum Infect Dis. 2024 Mar 21;11(4):ofae174. doi: 10.1093/ofid/ofae174. eCollection 2024 Apr.
6
Respiratory Syncytial Virus Infections in Neonates: A Persisting Problem.新生儿呼吸道合胞病毒感染:一个持续存在的问题。
Newborn (Clarksville). 2023 Jul-Sep;2(3):222-234. doi: 10.5005/jp-journals-11002-0073. Epub 2023 Sep 25.
7
Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants.观点:利用风险因素指导帕利珠单抗预防中度至晚期早产儿严重呼吸道合胞病毒感染的最佳方法
Front Pediatr. 2024 Jan 12;12:1343960. doi: 10.3389/fped.2024.1343960. eCollection 2024.
8
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.一项新的成本效益分析评估了帕利珠单抗针对 29-35 周龄胎龄出生的意大利婴儿进行的风险因素指导预防严重呼吸道合胞病毒感染的预防作用。
PLoS One. 2023 Aug 10;18(8):e0289828. doi: 10.1371/journal.pone.0289828. eCollection 2023.
9
Comparison of the Canadian vs. the international risk scoring tool for respiratory syncytial virus prophylaxis in moderate-to-late preterm infants.加拿大与国际风险评分工具用于中晚期早产儿呼吸道合胞病毒预防的比较
Front Pediatr. 2023 Jan 5;10:997349. doi: 10.3389/fped.2022.997349. eCollection 2022.
10
A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year.一项关于美国 1 岁以下婴儿呼吸道合胞病毒负担和医疗保健利用的系统文献综述。
J Infect Dis. 2022 Aug 15;226(Suppl 2):S195-S212. doi: 10.1093/infdis/jiac201.
对晚期早产儿毛细支气管炎的预后模型进行前瞻性验证:一项多中心出生队列研究。
PLoS One. 2013;8(3):e59161. doi: 10.1371/journal.pone.0059161. Epub 2013 Mar 12.
4
Respiratory function in healthy late preterm infants delivered at 33-36 weeks of gestation.33-36 孕周健康晚期早产儿的呼吸功能。
J Pediatr. 2013 Mar;162(3):464-9. doi: 10.1016/j.jpeds.2012.09.042. Epub 2012 Nov 6.
5
The evolution of risk factors for respiratory syncytial virus-related hospitalisation in infants born at 32-35 weeks' gestational age: time-based analysis using data from the FLIP-2 study.
J Perinat Med. 2012 Nov;40(6):685-91. doi: 10.1515/jpm-2011-0248.
6
Epidemiology of respiratory syncytial virus infection in infants born at less than thirty-five weeks of gestational age.小于三十五孕周出生婴儿的呼吸道合胞病毒感染的流行病学。
Pediatr Infect Dis J. 2012 Aug;31(8):e99-104. doi: 10.1097/INF.0b013e318257f619.
7
Respiratory syncytial virus--United States, July 2007-June 2011.呼吸道合胞病毒--美国,2007 年 7 月至 2011 年 6 月。
MMWR Morb Mortal Wkly Rep. 2011 Sep 9;60(35):1203-6.
8
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.美国 1997-2006 年与呼吸道合胞病毒相关的婴幼儿住院病例。
Pediatr Infect Dis J. 2012 Jan;31(1):5-9. doi: 10.1097/INF.0b013e31822e68e6.
9
Epidemiology and prevention of respiratory syncytial virus infections among infants and young children.婴幼儿呼吸道合胞病毒感染的流行病学和预防。
Pediatr Infect Dis J. 2011 Jun;30(6):510-7. doi: 10.1097/INF.0b013e3182184ae7.
10
Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study.年龄与婴儿呼吸道合胞病毒住院率的变化趋势:一项 8 年队列研究。
Adv Ther. 2011 Mar;28(3):195-201. doi: 10.1007/s12325-010-0106-6. Epub 2011 Feb 7.